RxDoctor Payments DataLook up a doctor →

Deanna Johnson, PA

Medical · Colorado Springs, CONPI 1659309631

Payments from drug & device makers

$40,916in general payments, 2019–2025

Across 1,110 payments — averaging $36.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • EMD Serono, Inc.$6K
  • TG Therapeutics, Inc.$6K
  • Livanova USA, Inc.$3K
  • AbbVie$3K
  • Biogen$2K
  • Abbott$2K
  • plus $19K from 54 others

What the payments were for

  • Consulting fees$3,5609%
  • Speaking & faculty fees$1,0793%
  • Travel & lodging$4,64511%
  • Food & beverage$31,47777%
  • Education$1550%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
EMD Serono, Inc.96$6,007
TG Therapeutics, Inc.78$5,576
Livanova USA, Inc.22$3,292
AbbVie(2 entities)142$2,593
Biogen78$2,307
Abbott28$2,002
Novartis59$1,309
Pfizer77$1,229
AstraZeneca36$1,146
Boston Scientific9$1,096
Supernus Pharmaceuticals, Inc.13$1,094
Sanofi28$956
Neurocrine Biosciences, Inc.39$875
Amgen(2 entities)20$745
UCB, Inc.21$731
Jazz Pharmaceuticals Inc.16$610
Genentech USA, Inc.16$606
Argenx US, Inc.15$598
SK Life Science, Inc.19$596
Merz Pharmaceuticals, LLC30$581
Bristol Myers Squibb36$492
Neurelis, Inc.11$458
Lilly USA, LLC20$443
Biohaven Pharmaceuticals, Inc.19$411
Acorda Therapeutics, Inc11$400
E.r. Squibb & Sons, L.L.C.5$371
Acadia Pharmaceuticals Inc14$367
Eisai Inc.14$365
Tanabe Pharma America, Inc.13$289
Biohaven Pharmaceutical Holding Company Ltd.14$285
Lundbeck LLC9$271
GRT US Holding, Inc.8$209
Otsuka America Pharmaceutical, Inc.4$189
Johnson & Johnson(2 entities)2$155
Mallinckrodt Hospital Products Inc.7$153
Catalyst Pharmaceuticals, Inc.6$144
Axsome Therapeutics, Inc.3$142
Medtronic2$138
Ipsen Biopharmaceuticals, Inc6$131
ANI Pharmaceuticals, Inc.5$121
Octapharma USA, Inc.5$115
Harmony Biosciences LLC4$108
Kyowa Kirin, Inc.6$107
Sunovion Pharmaceuticals Inc.5$101
Takeda Pharmaceuticals U.S.A., Inc.1$97
Teva Pharmaceuticals USA, Inc.5$96
CSL Behring3$89
Alnylam Pharmaceuticals Inc.4$78
MDD US Operations, LLC3$73
Greenwich Biosciences, Inc.3$66
Vanda Pharmaceuticals Inc.2$53
Amneal Pharmaceuticals LLC2$53
Avion Pharmaceuticals2$48
Ultragenyx Pharmaceutical Inc.2$42
Philips North America LLC1$42
Grifols USA, LLC1$40
Banner Life Sciences, LLC2$34
Janssen Scientific Affairs, LLC1$30
Blueprint Medicines Corporation1$27
GE HealthCare1$25

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$40,916 in reported general payments places this provider in the 95th percentile of 766 medical providers in Colorado.

See all medical providers in Colorado

Medicare billing

Part B allowed, 2024
$57,671
Medicare patients
211
Services billed
3,426

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Kesimpta PenOfatumumab55$552,996
EpidiolexCannabidiol (Cbd)14$133,460
Avonex (4 Pack)Interferon Beta-1a13$124,659
AubagioTeriflunomide11$100,473
Aimovig AutoinjectorErenumab-Aooe44$44,879
Dalfampridine ErDalfampridine64$39,325
Ajovy AutoinjectorFremanezumab-Vfrm43$39,263
XcopriCenobamate31$38,373
FycompaPerampanel29$36,316
Nurtec OdtRimegepant Sulfate27$31,950
UbrelvyUbrogepant23$31,662
BriviactBrivaracetam16$23,392
RytaryCarbidopa/Levodopa11$15,051
Emgality PenGalcanezumab-Gnlm16$14,782
Lacosamide61$8,375

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
BiogenAvonex (4 Pack)$2,307$124,65913 claims
SanofiAubagio$956$100,47311 claims
SK Life Science, Inc.Xcopri$596$38,37331 claims
Eisai Inc.Fycompa$365$36,31629 claims
PfizerNurtec Odt$1,229$31,95027 claims
AbbVieUbrelvy$2,593$31,66223 claims
UCB, Inc.Briviact$731$23,39216 claims
Amneal Pharmaceuticals LLCRytary$53$15,05111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 766 medical providers in Colorado.

Other medical in Colorado Springs

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →